Novo Holdings A/S’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $44.6M | Buy |
1,550,000
+275,000
| +22% | +$7.91M | 3.15% | 9 |
|
2025
Q1 | $42.8M | Buy |
1,275,000
+314,785
| +33% | +$10.6M | 3.25% | 10 |
|
2024
Q4 | $49.1M | Sell |
960,215
-39,785
| -4% | -$2.03M | 2.97% | 11 |
|
2024
Q3 | $51.1M | Hold |
1,000,000
| – | – | 2.54% | 13 |
|
2024
Q2 | $44.8M | Sell |
1,000,000
-98,600
| -9% | -$4.42M | 2.41% | 11 |
|
2024
Q1 | $51.4M | Sell |
1,098,600
-1,400
| -0.1% | -$65.5K | 3.55% | 7 |
|
2023
Q4 | $39.1M | Hold |
1,100,000
| – | – | 2.42% | 16 |
|
2023
Q3 | $32.7M | Hold |
1,100,000
| – | – | 2.42% | 18 |
|
2023
Q2 | $19.8M | Hold |
1,100,000
| – | – | 1.53% | 24 |
|
2023
Q1 | $17.7M | Buy |
1,100,000
+362,943
| +49% | +$5.83M | 1.17% | 25 |
|
2022
Q4 | $13.5M | Buy |
737,057
+105,430
| +17% | +$1.93M | 0.84% | 34 |
|
2022
Q3 | $12.4M | Hold |
631,627
| – | – | 0.59% | 30 |
|
2022
Q2 | $11.8M | Buy |
631,627
+206,730
| +49% | +$3.86M | 0.58% | 32 |
|
2022
Q1 | $9.33M | Buy |
+424,897
| New | +$9.33M | 0.49% | 37 |
|
2021
Q2 | – | Sell |
-271,378
| Closed | -$4.15M | – | 56 |
|
2021
Q1 | $4.15M | Hold |
271,378
| – | – | 0.17% | 46 |
|
2020
Q4 | $3.83M | Hold |
271,378
| – | – | 0.16% | 43 |
|
2020
Q3 | $4.25M | Buy |
271,378
+56,925
| +27% | +$892K | 0.21% | 41 |
|
2020
Q2 | $3.76M | Buy |
214,453
+50,000
| +30% | +$876K | 0.24% | 32 |
|
2020
Q1 | $2.42M | Buy |
164,453
+29,444
| +22% | +$433K | 0.16% | 28 |
|
2019
Q4 | $3.39M | Hold |
135,009
| – | – | 0.22% | 24 |
|
2019
Q3 | $2.03M | Hold |
135,009
| – | – | 0.35% | 25 |
|
2019
Q2 | $3.38M | Hold |
135,009
| – | – | 0.47% | 25 |
|
2019
Q1 | $3.07M | Hold |
135,009
| – | – | 0.45% | 20 |
|
2018
Q4 | $4.05M | Sell |
135,009
-14,991
| -10% | -$450K | 0.57% | 20 |
|
2018
Q3 | $4.3M | Buy |
+150,000
| New | +$4.3M | 0.34% | 21 |
|